Postoperative pulmonary complications are associated with increased morbidity, length of
hospital stay, and mortality after major surgery. Intraoperative lung-protective mechanical …

In December 2019, an outbreak of viral pneumonia caused by a novel coronavirus (since
named SARS-CoV-2) was identified in Wuhan, China. Within few months, this disease–now …

The severe respiratory consequences of the coronavirus disease 2019 (COVID-19) pandemic
have prompted urgent need for novel therapies. Cell-based approaches, primarily using …

A personalized mechanical ventilation approach for patients with adult respiratory distress
syndrome (ARDS) based on lung physiology and morphology, ARDS etiology, lung imaging, …

Background Nitazoxanide is widely available and exerts broad-spectrum antiviral activity in
vitro. However, there is no evidence of its impact on severe acute respiratory syndrome …

Severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) causes a wide spectrum
of clinical manifestations, with progression to multiorgan failure in the most severe cases. …

To test whether pulmonary and extrapulmonary acute lung injury (ALI) of identical mechanical
compromise would express diverse morphological patterns and immunological pathways. …

Coronavirus disease 2019 (COVID-19) can cause severe respiratory failure requiring
mechanical ventilation. The abnormalities observed on chest computed tomography (CT) and the …

Severe acute respiratory disease coronavirus 2 (SARS-CoV-2, formerly 2019-nCoV) is a
novel coronavirus that has rapidly disseminated worldwide, causing the coronavirus disease …

There is a growing experience demonstrating benefit of mesenchymal stromal cell (MSC)-based
cell therapies in preclinical models of asthma. In the current study, conditioned media (…